Study revives debate about unpopular diet for cancer pati...

What’s Happening

Here’s the thing: The neutropenic diet, which calls for nearly all food to be cooked at high heat to decrease infection risk, was waning in cancer care.

A new study could change that. Biotech Biotech STAT Plus: A seasoned biotech VC looks to 2026 and sees a wave of IPOs coming By Allison DeAngelis Neurotransmissions Neurotransmissions STAT Plus: What Ozempic might tell us about the future of Alzheimer’s By Jason Karlawish Politics Politics STAT Plus: 3 key issues to watch at FDA as Makary struggles to stabilize the agency By Lizzy Lawrence First Opinion First Opinion Researchers have a moral obligation to push back when their studies are twisted to promote false health claims By John Gregory Health Health American food safety could be headed for a breakdown By Sarah Todd STAT Plus: Data on Humana’s clinics looked dismal. (it feels like chaos)

Then its corporate research machine got to work By Casey Ross and Tara Bannow STAT Plus: FDA voucher program has become vehicle for political interference in drug review decisions, staffers say By Lizzy Lawrence STAT Plus: In a banner year for biopharma, here are the best industry CEOs of 2025 By Adam Feuerstein STAT Plus: Child’s sudden death unnerves a promising area of gene therapy research By Jason Mast STAT Plus: I’m the former head of Pfizer R&D.

Why This Matters

I’m worried about biopharma’s future By John L.

This is the kind of health news that affects everyday decisions.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

Is this a W or an L? You decide.